James Young
Chairman bei NOVAVAX, INC.
Vermögen: 335 030 $ am 31.03.2024
Profil
Derzeit bekleidet James F. Young die Position des Chairman von Novavax, Inc. und des President bei MedImmune Oncology, Inc. Dr. Young ist außerdem Mitglied des Vorstands von Sagimet Biosciences, Inc. und CannaRoyalty Corp. In seiner früheren Laufbahn war Dr. Young Vorsitzender von La Jolla Capital, Inc. und Vorsitzender, Chief Executive & Financial Officer bei Targeted Microwave Solutions, Inc. sowie President-Research & Development bei MedImmune LLC, Director-Molecular Genetics Department bei Smith Kline & French Laboratories Ltd. und Fakultätsmitglied an der Icah School of Medicine am Mount Sinai. James F. Young promovierte am Baylor College of Medicine und erwarb einen Bachelor-Abschluss an der Villanova University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NOVAVAX, INC.
0,05% | 12.06.2023 | 70 090 ( 0,05% ) | 335 030 $ | 31.03.2024 |
| 12.07.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von James Young
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVAVAX, INC. | Chairman | 20.04.2011 |
| ORIGIN HOUSE | Director/Board Member | - |
MedImmune Oncology, Inc.
 MedImmune Oncology, Inc. BiotechnologyHealth Technology MedImmune Oncology, Inc. engages in the clinical development of medicines to treat cancer. The company is headquartered in Gaithersburg, MD. | President | - |
Ehemalige bekannte Positionen von James Young
| Unternehmen | Position | Ende |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Director/Board Member | 13.07.2023 |
| TARGETED MICROWAVE SOLUTIONS INC. | Chief Executive Officer | 01.11.2018 |
Arriva Pharmaceuticals, Inc.
 Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications. Arriva’s current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California. | Director/Board Member | 10.07.2013 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | - |
| XENCOR, INC. | Director/Board Member | 01.01.2008 |
Ausbildung von James Young
| Villanova University | Undergraduate Degree |
| Baylor College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| ORTHOGONAL GLOBAL GROUP INC. | Finance |
| SAGIMET BIOSCIENCES INC. | Health Technology |
| TARGETED MICROWAVE SOLUTIONS INC. | Producer Manufacturing |
| Private Unternehmen | 7 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Arriva Pharmaceuticals, Inc.
Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications. Arriva’s current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California. | Health Technology |
Intercell USA, Inc.
 Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
Smith Kline & French Laboratories Ltd.
 Smith Kline & French Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Smith Kline & French Laboratories Ltd. manufactures pharmaceutical products. The company is headquartered in Brentford, the United Kingdom. | Health Technology |
CannaRoyalty Corp.
 CannaRoyalty Corp. Agricultural Commodities/MillingProcess Industries CannaRoyalty Corp. engages in the field of legal cannabis. The company was founded in February, 2015, and is headquartered in Ottawa, Canada. | Process Industries |
MedImmune Oncology, Inc.
MedImmune Oncology, Inc. BiotechnologyHealth Technology MedImmune Oncology, Inc. engages in the clinical development of medicines to treat cancer. The company is headquartered in Gaithersburg, MD. | Health Technology |
The Phillips Collection
 The Phillips Collection Other Consumer ServicesConsumer Services The Phillips Collection operates as an art museum that provides a collection of French impressionism and American modernism to contemporary art. The museum's collection includes works by American and European masters such as Paul Cézanne, Edgar Degas, Winslow Homer, Henri Matisse, Georgia O'Keeffe, Pablo Picasso, Mark Rothko, and Vincent van Gogh. The company was founded by Duncan Phillips and is headquartered in Washington, DC. | Consumer Services |
